Newtyn Management, LLC Theravance Biopharma, Inc. Transaction History

Newtyn Management, LLC

$567 Million
Q3 2024

A detailed history of Newtyn Management, LLC transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Newtyn Management, LLC holds 4,499,066 shares of TBPH stock, worth $43.1 Million. This represents 6.4% of its overall portfolio holdings.

Number of Shares

4,499,066

Previous 2,124,703 111.75%

Holding current value

$43.1 Million

Previous $18 Million 101.27%

% of portfolio

6.4%

Previous 3.93%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$7.66 - $10.25 $18.2 Million - $24.3 Million	2,374,363 Added 111.75%	4,499,066 $36.3 Million
Q2 2024 Aug 14, 2024	BUY	$8.29 - $9.92 $3.99 Million - $4.77 Million	480,773 Added 29.25%	2,124,703 $18 Million
Q1 2024 May 15, 2024	SELL	$8.22 - $11.59 $2.1 Million - $2.97 Million	-256,070 Reduced 13.48%	1,643,930 $14.7 Million
Q4 2023 Feb 14, 2024	BUY	$8.58 - $11.4 $501,415 - $666,216	58,440 Added 3.17%	1,900,000 $21.4 Million
Q3 2023 Nov 14, 2023	BUY	$8.38 - $10.44 $1.69 Million - $2.1 Million	201,104 Added 12.26%	1,841,560 $15.9 Million
Q2 2023 Aug 14, 2023	BUY	$10.16 - $11.92 $1.11 Million - $1.3 Million	109,441 Added 7.15%	1,640,456 $17 Million
Q1 2023 May 15, 2023	BUY	$9.87 - $11.44 $799,618 - $926,811	81,015 Added 5.59%	1,531,015 $16.6 Million
Q4 2022 Feb 14, 2023	SELL	$9.65 - $11.34 $10.1 Million - $11.9 Million	-1,045,860 Reduced 41.9%	1,450,000 $16.3 Million
Q3 2022 Nov 14, 2022	BUY	$8.39 - $10.22 $3.84 Million - $4.68 Million	458,035 Added 22.48%	2,495,860 $25.3 Million
Q2 2022 Aug 15, 2022	BUY	$8.41 - $10.34 $5.57 Million - $6.85 Million	662,825 Added 48.21%	2,037,825 $18.5 Million
Q1 2022 May 16, 2022	BUY	$8.33 - $12.96 $3.12 Million - $4.86 Million	375,000 Added 37.5%	1,375,000 $13.1 Million
Q4 2021 Feb 14, 2022	BUY	$7.42 - $11.05 $6.69 Million - $9.97 Million	902,045 Added 920.88%	1,000,000 $11.1 Million
Q3 2021 Nov 15, 2021	BUY	$6.77 - $14.41 $663,155 - $1.41 Million	97,955 New	97,955 $725,000
Q1 2020 May 15, 2020	SELL	$17.84 - $31.21 $3.09 Million - $5.41 Million	-173,300 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$16.12 - $25.89 $1.77 Million - $2.84 Million	109,619 Added 172.14%	173,300 $4.49 Million
Q3 2019 Nov 14, 2019	BUY	$16.51 - $23.78 $1.05 Million - $1.51 Million	63,681 New	63,681 $1.24 Million

Others Institutions Holding TBPH

# of Institutions

122

Shares Held

47.3M

Call Options Held

200

Put Options Held

12.8K

View Full List

About Theravance Biopharma, Inc.

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $640M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

More about TBPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Newtyn Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Newtyn Management, LLC with notifications on news.

Account

Newtyn Management, LLC Theravance Biopharma, Inc. Transaction History